Clinical Trial Update: Paxlovid for Treatment of Long Covid [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated Paxlovid (nirmatrelvir/ritonavir) for treatment of Long COVID/Post-acute Sequelae of SARS-CoV-2 Infection; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• PAXLOVID (Nirmatrelvir and ritonavir)

Snippet

Sponsor: Stanford University | Conditions: Post-acute Sequelae of SARS-CoV-2 Infection, Long COVID | Phase 2 | Status: COMPLETED | Results posted: 2024-09-25